Loading…
Abbott Laboratories is projected to rise to $118.42 by 2027, a +13% move from its current price of $104.49. ABT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 29 | $102.74 | $104.50 | $106.28 | +0.01% |
| Jul 30 | $102.03 | $104.50 | $107.04 | +0.01% |
| Jul 31 | $101.49 | $104.51 | $107.62 | +0.02% |
| Aug 1 | $101.04 | $104.52 | $108.12 | +0.03% |
| Aug 2 | $100.64 | $104.52 | $108.56 | +0.03% |
| Aug 3 | $100.28 | $104.53 | $108.96 | +0.04% |
| Aug 4 | $99.96 | $104.54 | $109.33 | +0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $99.96 | $104.54 | $109.33 | +0.05% |
| Week 2 | $98.16 | $104.59 | $111.43 | +0.09% |
| Week 3 | $96.82 | $104.64 | $113.08 | +0.14% |
| Week 4 | $95.71 | $104.69 | $114.51 | +0.19% |
| Week 5 | $94.74 | $104.73 | $115.78 | +0.23% |
| Week 6 | $93.89 | $104.78 | $116.95 | +0.28% |
| Week 7 | $93.11 | $104.83 | $118.03 | +0.33% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.
It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915.
Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
Abbott Laboratories (ABT) is a healthcare company with a broad portfolio across pharmaceuticals, diagnostics, nutrition, and medical devices. It currently trades at $101.66 per share, with a market capitalization of $177.07B and a market rank of 77.
The stock sits within a near-term technical framework that reflects constructive momentum, supported by a bullish tilt in price action. The 30-day snapshot includes a price range that spans from $91.09 to $113.46, signaling how the stock has traded recently.
Key levels to watch include a support at $87.83 and a resistance at $101.66, with the 50-day moving average at $89.97 and the 200-day moving average at $109.67. These technical marks help illustrate the stock’s current position within its broader trend.
A major floor 21.3% below — a decisive break under it would weaken the trend.
The nearest floor, 15.9% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 10.6% above — clearing it would confirm fresh momentum.
Key ABT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ABT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $101.43 | Buy | $101.30 | Buy |
| MA 10 | $97.70 | Buy | $99.13 | Buy |
| MA 20 | $95.86 | Buy | $96.54 | Buy |
| MA 50 | $91.31 | Buy | $94.33 | Buy |
| MA 100 | $95.64 | Buy | $97.51 | Buy |
| MA 200 | $109.02 | Sell | $105.17 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 69.55 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 161.42 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.87 | Buy |
| ROC (12) | 9.78 | Buy |
| Bollinger %B (20,2) | 1.01 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.33 | Buy |
| Awesome (5,34) | 8.04 | Buy |
| Ultimate (7,14,28) | 79.91 | Sell |
| Momentum (10) | 10.56 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 103.04 | Buy |
| ADX (14) | 21.97 | Buy |
| ATR (14) | 1.78 | Info |
The near-term technical picture remains bullish, with RSI(14) at 70, indicating strong momentum and potential overbought conditions near the top of the range.
The stock’s moving averages show the 50-day line at $89.97 and the 200-day line at $109.67, suggesting a consolidation around the mid-to-upper end of the recent range. The 30-day range spans $91.09 to $113.46, highlighting the upper limit being near the current price level of $101.66 and the lower limit providing nearby support.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $82.56 | $104.49 | $131.48 | 0% | Neutral | |
| $97.08 | $118.42 | $150.96 | +13% | Neutral | |
| $103.99 | $129.26 | $169.29 | +24% | Bullish | |
| $106.09 | $133.92 | $179.16 | +28% | Bullish | |
| $115.80 | $148.17 | $201.82 | +42% | Bullish | |
| $131.01 | $169.67 | $234.78 | +62% | Bullish | |
| $148.45 | $194.45 | $272.92 | +86% | Bullish | |
| $160.86 | $212.93 | $302.73 | +104% | Bullish | |
| $162.27 | $216.94 | $312.13 | +108% | Bullish | |
| $166.41 | $224.57 | $326.72 | +115% | Bullish | |
| $243.66 | $343.00 | $523.00 | +228% | Bullish | |
| $432.54 | $653.05 | $1,067.51 | +525% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $82.56 | $104.49 | $122.63 | +0.00% |
| August 2026 | $90.55 | $105.65 | $125.69 | +1.11% |
| September 2026 | $89.60 | $105.13 | $126.20 | -0.50% |
| October 2026 | $91.00 | $107.25 | $129.69 | +2.02% |
| November 2026 | $92.16 | $109.02 | $132.60 | +1.64% |
| December 2026 | $90.58 | $107.52 | $131.48 | -1.37% |
Click any year to see its month-by-month ABT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ABT could reach as high as $131.48, with a base case around $104.49 and support toward $82.56 — roughly 0% from $104.49. Price action looks broadly range-bound.
Expect ABT to range from $97.08 to $150.96 through 2027. The $118.42 average target implies a +13% move from current prices. That is up +13% on the projected 2026 average. A consolidation phase looks the most probable path here.
The ABT price prediction for 2028 points to an average of $129.26 (low $103.99, high $169.29) — a potential gain of +24% on today's $104.49. Momentum favours further upside here.
In 2029, ABT is projected to trade between $106.09 and $179.16, averaging $133.92 — a potential gain of +28% from today's $104.49. That is up +4% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Abbott Laboratories's 2030 outlook centres on $148.17, within a $115.80 to $201.82 range. That is up +11% on the projected 2029 average. That marks a +42% change versus current levels. Momentum favours further upside here.
By 2031, ABT could reach as high as $234.78, with a base case around $169.67 and support toward $131.01 — roughly +62% from $104.49. Buyers look set to stay in control over this stretch.
Expect ABT to range from $148.45 to $272.92 through 2032. The $194.45 average target implies a +86% move from current prices. That is up +15% on the projected 2031 average. Momentum favours further upside here.
The ABT price prediction for 2033 points to an average of $212.93 (low $160.86, high $302.73) — a potential gain of +104% on today's $104.49. Buyers look set to stay in control over this stretch.
In 2034, ABT is projected to trade between $162.27 and $312.13, averaging $216.94 — a potential gain of +108% from today's $104.49. That is up +2% on the projected 2033 average. Momentum favours further upside here.
Abbott Laboratories's 2035 outlook centres on $224.57, within a $166.41 to $326.72 range. That is up +4% on the projected 2034 average. That marks a +115% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ABT could reach as high as $523.00, with a base case around $343.00 and support toward $243.66 — roughly +228% from $104.49. Momentum favours further upside here.
Expect ABT to range from $432.54 to $1,067.51 through 2050. The $653.05 average target implies a +525% move from current prices. That is up +90% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ABT today (≈ 9.570294 ABT) could be worth
$6,249.87
+$5,249.87 (+525%) by 2050 · US Dollar
Based on the average projected ABT price of $653.05 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ABTwould be worth at today's price.
$1,000 invested in ABT on Jul 28, 2025 (≈ 7.914523 ABT) would be worth
$826.99
-$173.01 (-17.3%) today · 0.83× · US Dollar
Based on a ABT entry price of $126.35 vs. today's $104.49.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $101.66 | $1,027.84 | +2.8% |
| 1 month ago | $94.12 | $1,110.18 | +11.0% |
| 3 months ago | $93.86 | $1,113.25 | +11.3% |
| 6 months ago | $106.05 | $985.29 | -1.5% |
| 1 year ago | $126.35 | $826.99 | -17.3% |
| All time (5.0y) ago | $121.09 | $862.91 | -13.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ABT forecast.
Our base-case forecast reaches $210.00 around 2033.
Implied market cap at $210.00: $365.78B
The multi-year forecast delivers a progressively higher trajectory, with the average price climbing from $101.66 in 2026 to well over half a thousand dollars by 2050. In 2027 the average is $115.11 with an ROI of 13.2; in 2028 it is $124.97 with an ROI of 22.9; and in 2029 it is $127.92 with an ROI of 25.8. By 2030 the average is $142.12 and the ROI rises to 39.8, followed by 2031 at $161.83 (59.2) and 2032 at $184.24 (81.2).
The path continues to 2033 at $202.97 (99.7) and 2034 at $204.79 (101.5), then 2035 at $210.90 (107.5). The forecast extends to 2040 with an average of $321.02 (215.8) and to 2050 with an average of $604.43 (494.6). In this outlook, sentiment shifts to bullish from 2028 onward and remains positive through 2050.
These figures are estimates and not guarantees, and actual results may differ due to market and company-specific factors.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $142.12 with a minimum of $111.05 and a maximum of $193.65, and an ROI of 39.8 with a bullish sentiment.
Forecasts show rising average prices from 2026 ($101.66) to 2050 ($604.43) with increasing ROI (up to 494.6) and bullish sentiment in later years, though these are estimates and not guarantees.
Yes. The 2026 forecast lists an average of $101.66 and a minimum of $82.56 with a 2027 average of $115.11, indicating the ability to move above $100 in the near to mid term.
The 2040 forecast shows an average price of $321.02 with a ROI of 215.8 and a bullish sentiment.
The 2050 forecast shows an average price of $604.43 with a ROI of 494.6 and a bullish sentiment.
Abbott Laboratories Community Discussion
0Share your Abbott Laboratories price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.